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Effects of collagen-derived 
bioactive peptides and natural 
antioxidant compounds on 
proliferation and matrix protein 
synthesis by cultured normal 
human dermal fibroblasts
Suzanne Edgar1, Blake Hopley1, Licia Genovese2, Sara Sibilla2, David Laight1 & Janis Shute1
Nutraceuticals containing collagen peptides, vitamins, minerals and antioxidants are innovative 
functional food supplements that have been clinically shown to have positive effects on skin hydration 
and elasticity in vivo. In this study, we investigated the interactions between collagen peptides 
(0.3–8 kDa) and other constituents present in liquid collagen-based nutraceuticals on normal primary 
dermal fibroblast function in a novel, physiologically relevant, cell culture model crowded with 
macromolecular dextran sulphate. Collagen peptides significantly increased fibroblast elastin synthesis, 
while significantly inhibiting release of MMP-1 and MMP-3 and elastin degradation. The positive effects 
of the collagen peptides on these responses and on fibroblast proliferation were enhanced in the 
presence of the antioxidant constituents of the products. These data provide a scientific, cell-based, 
rationale for the positive effects of these collagen-based nutraceutical supplements on skin properties, 
suggesting that enhanced formation of stable dermal fibroblast-derived extracellular matrices may 
follow their oral consumption.
The biophysical properties of the skin are determined by the interactions between cells, cytokines and growth fac-
tors within a network of extracellular matrix (ECM) proteins1. The fibril-forming collagen type I is the predomi-
nant collagen in the skin where it accounts for 90% of the total and plays a major role in structural organisation, 
integrity and strength2. A complex network of interlaced collagen fibrils in the dermis provides support to the 
epidermis, and together with elastin and microfibrils gives the skin its elasticity and resilience1. In addition, pro-
teoglycans and polymeric oligosaccharides, including abundant hyaluronic acid, play a key role in skin hydration.
Collagen I, elastin and proteoglycans, the three major groups of dermal ECM proteins, are secreted mainly 
by dermal fibroblasts activated by TGFβ, a multifunctional growth factor regulating the expression, deposition 
and turnover of skin extracellular matrix proteins1. Production of collagen and of the other components of the 
extracellular matrix is high when there is a sufficient level of mechanical tension on fibroblasts. When this ten-
sion is reduced, for example with age, the production of the matrix proteins falls and there is an increase of 
matrix-degrading enzymes3. The mature interstitial collagen fibrils are resistant to most proteolytic enzymes, but 
are susceptible to degradation by the collagenolytic matrix metalloproteinases MMP-1, MMP-8 and MMP-134. 
Elastolytic MMPs include the macrophage metalloelastase MMP-12 and the weakly elastolytic MMP-3 which is 
expressed by fibroblasts.
The skin is subject to intrinsic (chronological) and extrinsic (environmental and lifestyle factors including 
UV radiation and smoking) ageing, which are both associated with histopathological and immunohistochem-
ical changes5. Intrinsic ageing is characterised by cell senescence6, and altered levels of collagen7, elastin8 and 
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glycosaminoglycans, including hyaluronic acid9. In extrinsic ageing, there is loss of reticular collagen and an 
accumulation of disorganised elastic fibres and glycosaminoglycans. Photo-aged skin (UV-irradiated) displays 
alterations of the extracellular matrix, with an increase in the expression of matrix metalloproteinases and colla-
genases10. Increased expression and activity of MMPs, notably MMP-1, MMP-3 and MMP-911,12, has been associ-
ated with photo-ageing, and a direct effect of UV on the integrity of elastic microfibril associated proteins and on 
the elastin network has been suggested8,13.
A major cause of ageing-related skin damage is thought to be a consequence of decreased antioxidant defences 
leading to increased levels of intracellular reactive oxygen species (ROS). These form through aerobic metabolism 
and stimulate signal transduction resulting in the increased expression of MMPs and decreased collagen I syn-
thesis14. The generation of ROS has been directly associated with protein damage, and with up-regulation in the 
expression and activity of MMPs in intrinsically and extrinsically aged skin15,16. Moreover, the ECM proteins can 
work as skin photo-sensitizers, enhancing the genotoxicity of a given dose of UV irradiation, contributing there-
fore to skin photo-ageing17. With age, the imbalance between synthesis and degradation of the ECM proteins leads 
to glycation and the consequent formation and accumulation of AGEs (advanced glycation end-products), which 
are a hallmark of age-related diseases18. Further, with age, the ability to replenish collagen naturally decreases by 
about 1% per year19. Thus, the administration of antioxidants might help in counteracting ROS-induced signs of 
ageing20. Along this line, it was shown that the administration of antioxidants can decrease oxidative stress in a 
model of prematurely ageing mice21. Moreover, clinical studies have shown that the oral administration of antiox-
idants can help improve skin condition in photo-aged skin22,23 and UV-induced erythema24.
In addition, evidence from placebo-controlled clinical studies supports the notion that daily oral consumption 
of collagen peptides derived by hydrolysis of native porcine and piscine collagen improves the density and integ-
rity of the collagen network, hydration and elastic properties of normal skin25,26. Further, dietary supplements 
combining piscine collagen peptides with other active ingredients including hyaluronic acid, antioxidants, vita-
mins and minerals improve the appearance of the ageing skin27–29. However, the cellular mechanisms underpin-
ning these observations remain to be elucidated.
The aim of this in vitro study is to investigate the effects on normal human dermal fibroblast synthesis of col-
lagen I and elastin, release of transforming growth factor-β (TGF-β), plasminogen activator inhibitor-1 (PAI-1), 
matrix metalloproteinases (MMP), MMP-1 and MMP-3, and elastin degradation of collagen bioactive peptides, 
alone and in combination with other bioactive compounds found in two different collagen-based nutraceutical 
supplements previously reported to increase skin elasticity in vivo28,29.
Our hypothesis is that the antioxidant activity associated with the additives within these nutraceutical prod-
ucts interacts with the effects of the collagen peptides to enhance the stability of matrix proteins by inhibiting 
release of MMP-1 and MMP-3 in dermal fibroblast culture.
Materials and Methods
Test products. The collagen peptides, natural antioxidants and other bioactive molecules tested in this study 
are those found in the collagen-based nutraceutical supplements ACTIVE GOLD COLLAGEN® (ACTIVE) and 
GOLD COLLAGEN® FORTE (FORTE), which are manufactured by Minerva Research Labs (London, UK). The 
collagen peptides component (0.3–8 kDa; Peptan® by Rousselot) was tested on normal primary human dermal 
fibroblasts in culture in the absence and presence of a full combination of other active ingredients at the con-
centrations shown in Table 1. These data are presented in the main results section. The collagen peptides were 
also tested following addition of individual active ingredients in the combinations shown in Table 1 to investi-
gate possible additive effects of individual components. These data are described in the main results section and 
are presented graphically in Supplementary Figs S3–S8.
Collagen Peptides Production. Peptan® collagen peptides are produced by hot water extraction of the 
endogenous collagen from fish skin, filtration, concentration, subsequent standardized and controlled enzymatic 
hydrolysis, sterilization and spray-drying. The production follows GMP guidelines and is HAACP-controlled in 
a IFS and ISO certified plant.
Molecular Weight distribution. The molecular weight of Peptan® collagen peptides is between 0.3 and 
8 KDa. The molecular weight distribution of these collagen peptides is determined by high performance size 
exclusion chromatography (HPSEC) using an Agilent HPLC, 1260 Infinity series (G1316A, G1329B, G1311C, 
G1315D) with a TSKgel SWXL precolumn und a G2000SWXL column (Tosoh Bioscience). Analysis is performed 
with the WinGPC software (PSS). Samples are eluted from the column with 170 mM phosphate buffer contain-
ing 15% acetonitril and monitored with UV detection. Calibration is performed with the Narrow Calibration 
Standard (Low FILK).
Amino Acids composition. The samples were hydrolysed in 9 M HCl at 110 C for 20 h, and subsequently 
derivatized and stabilized by 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate (AccQ-Fluor reagent kit 
WAT052880). These fluorescent derivatives were separated by RP-HPLC on a Waters 2695 Alliance HPLC 
Separation Module and detected by a fluorescent detector. Quantification is performed by the Software Waters 
– Empower 3 using standards for each amino acid (Amino Acid Standard H WAT088122). Peptan® collagen pep-
tides are characterised by a high content of Glycine, Hydroxyproline/Proline and Glutamic Acid which represent 
56% of the total amino acids. These collagen peptides comprise also Arginine (8%), Alanine (8%), essential amino 
acids (16%) and other amino acids (12%).
Cell Culture. Normal adult human dermal fibroblasts (NHDF) were purchased from Lonza (Walkersville, 
MD, USA) and grown in fibroblast growth medium-2 (FGM), containing 2% FBS (Lonza), at 37 °C and 5% CO2. 
Cells at passage 3–7 were seeded into 24 and 96 well plates at a density of 5 × 104 cells/well, and 5 × 103 cells/well 
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for protein analysis and proliferation assays respectively. The fibroblasts were grown for 16 hours, quiesced for 
24 h in medium containing 0.3% FBS and then treated for 48 hours with combinations of the bioactive constitu-
ents of ACTIVE or FORTE (Table 1) at a concentration found in a 1:50 dilution of the whole product. The ration-
ale for testing components at this dilution is based on the absorption and distribution of avian collagen peptides 
of similar composition in an animal model, as detailed in the Supplementary Material.
These treatments were added in FGM containing 0.3% FBS, supplemented with 100 µM L-ascorbic acid and 
100 µg/ml > 500 kDa dextran sulphate (Sigma-Aldrich, St. Louis, USA), which will be referred to hereafter as 
‘crowded medium’30,31. Under these conditions cells remained viable, as confirmed by their adherence to cell 
culture plates and proliferation over 48 hours, as described in section 2.7. In all experiments, cell culture super-
natants were collected, cleared by centrifugation at 1000 g for 10 minutes (min) at 4 °C and stored at −80 °C until 
assayed.
Collagen I. Cells were washed twice with phosphate buffered saline. Cell-associated collagen was solubilised 
by the addition of 0.5 M acetic acid (250 µl/well) and gentle agitation at 4 °C for 32 hours, before adding 0.1 mg/ml 
pepsin from porcine mucosa (Sigma-Aldrich) and continuing agitation for a further 16 hours. Pepsin digestion 
was then inhibited with 2 µg/ml pepstatin A (Sigma-Aldrich). Cell samples were stored at -80 °C until assayed. A 
novel quantitative immuno-blot assay for native collagen I was developed and validated by Western blot analysis 
of TGFβ-activated NHDF cells and supernatants (Supplementary Fig. S1). Standards (0.625–10 ng calf skin col-
lagen I, Sigma Aldrich) and samples (100 µl) diluted with PBS (acid-soluble cell fraction, 1:10, and supernatants, 
1:20), were loaded onto nitrocellulose membrane using a vacuum manifold to create protein dots. Blots were 
dried, blocked with 5% dried skimmed milk powder and 2% Tween 20 in PBS and incubated overnight at 4 °C 
with rabbit anti collagen I antibody (Abcam, Cambridge, UK) at 200 ng/ml in block buffer. The blots were then 
incubated with 50 ng/ml goat anti rabbit-HRP antibody (Dako, Glostrup, Denmark) for 1 hour at room tempera-
ture. Blots were visualised using chemiluminescence (Thermo-Fisher, Waltham, USA).
Elastin. Cells were lifted with trypsin-EDTA (Sigma-Aldrich) and diluted 3:1 with 1 M oxalic acid to 0.25 M 
oxalic acid. Cell samples were incubated at 95–100 °C for 2 hours, with intermittent mixing, and the entire cell and 
supernatant samples from each well were assayed separately for solubilised elastin using the Fastin elastin assay 
kit (Biocolor, Carrickfergus, UK), following manufacturer’s instructions.
AP-1 analysis. NHDF were lysed in 20 mM TRIS-HCl, pH 7.6, containing 150 mM NaCl plus 1% Triton 
X-100, lysis buffer and 2 × protease inhibitors, protease cocktail I (Calbiochem), and Complete® protease inhibi-
tor (Roche), PhosSTOP® phosphatase inhibitor (Roche), 4 mM MgCl2 and benzonase (Sigma-Aldrich) at 1:1000 
dilution in sample buffer (35 ul per well of 24-well plate).
Samples were mixed with sample buffer and separated on 10% SDS-PAGE and proteins transferred to nitro-
cellulose using semi-dry electrophoresis. Membranes were blocked with 3% dried skimmed milk powder in 
ACTIVE GOLD COLLAGEN® constituents Antioxidant activity Combinations tested
Code Constituent µg/ml TE (µM) No. Addition
C Hydrolysed piscine collagen 2000 76 1 C
HA Hyaluronic acid 0.8 nd 2 C + HA
G Glucosamine hydrochloride 400 nd 3 C + HA + G
CA L-carnitine 400 10 4 C + HA + G + CA
M Dried Maca root extract 8 93 5 C + HA + G + CA + M
P Piperine (Piper Nigrum seed extract) 0.6 41 6 C + HA + G + CA + M + P
GOLD COLLAGEN® FORTE constituents
Code Constituent µg/ml TE (µM) No. Addition
C Hydrolysed piscine collagen 2000 76 1 C
CS Carnosine 24 44 2 C + CS
Q10 CoEnzyme Q10 10 19 3 C + CS + Q10
R Resveratrol (red wine powder extract) 1 338 4 C + CS + Q10 + R
O Borage seed oil/Primrose oil 10 95 5 C + CS + Q10 + R + O
HA Hyaluronic acid 16 6 6 C + CS + Q10 + R + O + HA
P Piperine (Piper Nigrum seed extract) 0.6 41 7 C + CS + Q10 + R + O + HA + P
L Lycopene (tomato pulp extract) 0.04 64 8 C + CS + Q10 + R + O + HA + P + L
A Acai berry extract 12 115 9 C + CS + Q10 + R + O + HA + P + L + A
PO Pomegranate juice (concentrated) 8 95 10 C + CS + Q10 + R + O + HA + P + L + A + PO
Table 1. The concentrations at which collagen peptides alone and in combination with other individual 
bioactive constituents of the nutraceuticals, ACTIVE and FORTE, were tested in normal dermal fibroblast 
cultures. The antioxidant activity measured as Trolox equivalents (TE) by peroxyl scavenging is shown for the 
individual constituents (mean, n = 4); nd = not detected. Combination number 6 for the ACTIVE constituents 
and combination number 10 for the FORTE constituents correspond to ‘All’.
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TRIS (20 mM) buffered saline (150 mM) plus 0.1% Tween-20, and stained with rabbit anti-p-c-jun (Ser 63/73) 
at 200 ng/ml, and secondary goat-anti-rabbit-HRP (Sigma-Aldrich) at 1:2000 dilution. Chemiluminescence 
(Promega) was used to detect bands following 30 mins exposure in the ChemiDoc imager (BioRad).
ELISAs. Cells were lysed using hypotonic lysis buffer (1% Triton X-100 in 10 mM Tris-HCl buffer, pH 7.4) 
containing 2 × protease cocktail I inhibitors (Merck (Calbiochem), Darmstadt, Germany) and stored at −80 °C 
until assayed. Supernatants were analysed neat for TGF-β, PAI-1 and desmosine, and at a 1:25 dilution for MMPs 
-1 and-3. Total TGF-β, total MMP-1, total MMP-3, TIMP-1 and PAI-1 ELISA kits from R&D systems (Abingdon, 
UK) were used according to the manufacturer’s instructions.
A desmosine ELISA was performed using an in-house competitive ELISA as previously described32. In brief, 
the wells of a 96-well Nunc maxisorp microtitre plate were coated with 250 ng desmosine-egg-albumin complex 
(Elastin Products Company (EPC), Missouri, USA) in 100 µl bicarbonate buffer, pH 9.6 (Sigma-Aldrich), over-
night at 4 °C. Desmosine standards (EPC) were prepared in the range 0–2000 ng/ml in 100 mM Tris-HCl pH 7.2, 
containing 0.1%Tween-20. Standards and samples (100 µl) were added to 200 µl of a 1:3000 rabbit anti-desmosine 
serum (EPC) and incubated at 37 °C for 30 min. Plates were washed, and standards and samples (100 µl in dupli-
cate) were added to the wells and incubated for 2 h at 4 °C. Biotinylated swine anti-rabbit (Dako) antibody, 100 µl 
at 1:1000 dilution, was added to each well and incubated for 1 h at room temperature. Streptavidin-HRP com-
plexes (Vector Labs), 100 µl at 1:1000 dilution, were added for 30 min at room temperature, followed by substrate 
(5.5 mM o-phenylene-diamine solution in TRIS-citrate buffer pH 6). Reactions were stopped by the addition of 
100 ul 2 M H2SO4 and the plate read at 490 nm.
Cell Proliferation. The proliferation assay was performed after 48 hours of cell culture, as described in sec-
tion 2.2, using the CyQuant NF assay kit (Thermo Fisher) according to the manufacturer’s instructions. A stand-
ard curve to calculate cell number was prepared with 100–50,000 cells per well, in triplicate, which were allowed 
to adhere for 4 h, then stained with CyQuant dye binding solution for 40 min, and fluorescence was measured at 
excitation/emission wavelengths 485/530.
Antioxidant activity. The antioxidant activity of the collagen peptides and the other bioactive ingredients 
tested was measured using a pyranine-based procedure to evaluate the total peroxyl scavenging capacity33,34. The 
method is based on the ability of antioxidants to prevent the bleaching of pyranine (200 μM) by peroxyl radicals 
generated from AAPH (2,2′-azo-bis- (2-amidinopropane) hydrochloride (200 mM). Trolox, a water-soluble ana-
logue of vitamin E was used as a standard and values were expressed as Trolox equivalents (TE). Samples (25 μl) 
were mixed with 25 μl pyranine and incubated for 3 min at 37 °C. AAPH (50 μl) was added and the reaction 
monitored at 454 nm every minute for 80 min. The lag phase to bleaching was determined for samples and Trolox 
standards in the range 0 to 0.5 mM. Reagents were all from Sigma-Aldrich.
Statistical analysis. Fibroblast responses are presented as mean ± sem and were analysed by one-way 
ANOVA followed by Fisher’s LSD post-hoc test using GraphPad Prism, version 7, software. Correlation between 
the cumulative antioxidant activity of individual bioactives and elastin, MMP-1 and MMP-3 levels in NHDF cul-
tures was analysed by one-tailed Pearson correlation coefficient test. Differences where p < 0.05 were considered 
to be statistically significant.
Results
It has previously been reported that TGF-β at 5 ng/ml strongly stimulates collagen synthesis by embryonic pulmo-
nary fibroblasts in crowded culture30. Therefore, because TGF-β controls expression, deposition and turnover of 
collagens and other extracellular matrix proteins in the skin1, and primary dermal fibroblast responses to TGF-β 
as a positive control in cultures crowded with high molecular weight dextran sulphate have not previously been 
reported, we initially tested the effect of TGF-β (5 ng/ml) on NHDF protein synthesis and proliferation after 
48 hour incubation under similarly crowded conditions, compared to media alone (Fig. 1). The values for baseline 
concentrations of all proteins in quiescent cultures are presented in the legend to Fig. 1. Significantly more colla-
gen I was found in the supernatant (2.5 ± 0.6 ng/well) compared to the cell layer (0.6 ± 0.2 ng/well). These values 
were normalised to 100% to test the relative effect of TGF-β. TGF-β stimulated a significant increase in collagen 
I in the cell lysate (942.0 ± 268.3%; Fig. 1a) and supernatant (154.6 ± 20.7%; Fig. 1b) compared to media alone 
(100%). Unlike collagen I, significantly more elastin was found, in quiescent cultures, associated with cell layers 
(11.4 ± 1.9 µg/well) compared to supernatants (6.5 ± 0.8 µg/well). Further, TGF-β significantly increased elastin 
in the cell lysate (165.1 ± 35.1%; Fig. 1d) and supernatant (151.8 ± 5.5%; Fig. 1e). TGF-β significantly decreased 
total MMP-1 (42 ± 7.4%; Fig. 1c), total MMP-3 (58.1 ± 9.9%; Fig. 1f) and desmosine (75.4 ± 4.1%; Fig. 1h) in the 
culture supernatants, significantly increased PAI-1 (721.2 ± 96.5%; Fig. 1g) in the supernatant and significantly 
increased the proliferation of NHDF (121.0 ± 5.4%; Fig. 1i) compared to the effect of media alone, normalised 
to 100%.
The effects of the addition of collagen peptides alone (C) and in combination with all the other bioactive and 
antioxidant constituents (All) present within the two nutritional supplements, ACTIVE and FORTE, at the con-
centrations described in Table 1, were tested and compared to the effect of media alone (designated as the 100% 
value in all experiments). In parallel, the effect of adding individual constituents to the collagen peptides, in the 
combinations described in Table 1, were tested and these results are presented in Supplementary Figs S3–S8. 
Collagen I, elastin and TGF-β synthesis by NHDF was measured in both the cell lysate and supernatant. PAI-
1, MMP-1, MMP-3, TIMP-1 and desmosine were measured in the supernatant alone where they were most 
abundant.
Collagen I was found predominantly in soluble form when cells were grown in media alone (Fig. 2, legend). 
Although collagen peptides alone had no significant effect on collagen I in the supernatant, soluble collagen I was 
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significantly increased in response to the combination of collagen peptides with the other five ACTIVE constit-
uents tested (All; 265.8 ± 169% of media control; Fig. 2b). Similarly, although cell-associated collagen in the cell 
lysate was not significantly increased in response to collagen peptides alone (C; 142.5 ± 32.2%), in combination 
with all other ACTIVE constituents cell lysate collagen was significantly increased (All; 196.2 ± 16.2%; Fig. 2a). 
Considering the individual combinations of ACTIVE constituents (Table 1, Fig. Supplementary Fig. S3a) all those 
including glucosamine in combination with hyaluronic acid and collagen peptides, but not hyaluronic acid or col-
lagen peptides alone, significantly increased cell-associated collagen I (Supplementary Fig. S3a,c). In contrast, the 
combination of collagen peptides with the other nine constituents of FORTE (All) did not increase cell-associated 
or soluble collagen I (Fig. 2c,d).
Unlike collagen, elastin was found predominantly in cell lysates in unstimulated cultures (Fig. 3, legend). The 
addition of collagen peptides alone (C) significantly increased the amount of soluble elastin (Fig. 3b,d). Moreover, 
in combination with the nine other bioactive constituents of FORTE (All) the effect was further significantly 
enhanced (Fig. 3d).
Although all combinations (Table 1, Supplementary Fig. S4c,d) of the FORTE and ACTIVE constituents 
increased soluble elastin in the supernatant compared to media alone, only FORTE constituents stimulated a 
further significant increase in soluble elastin compared to the collagen peptides alone (Supplementary Fig. S4d). 
However, there was no significant increase in the cell-associated elastin in cell lysates on addition of collagen 
peptides to any combination with other bioactives (Fig. 3a,c, Supplementary Fig. S4a,b).
Addition to dermal fibroblast cultures of the whole ACTIVE and FORTE products (including acidity regula-
tors, stabilisers, natural sweeteners, flavourings and vitamins) at 1:50 dilution, to match the tested concentrations 
of individual components, significantly increased soluble elastin to 173 ± 27.9% and 187 ± 40%, respectively, of 
the media control value.
M ed ia TG F -ß 1
0
5 0 0
1 0 0 0
1 5 0 0
C
e
ll
L
y
s
a
te
C
o
ll
a
g
e
n
(%
)
* *
M ed ia TG F -ß 1
0
5 0
1 0 0
1 5 0
2 0 0
S
o
lu
b
le
C
o
ll
a
g
e
n
(%
)
* *
M ed ia TG F -ß 1
0
5 0
1 0 0
1 5 0
M
M
P
-1
(%
)
* * * *
M ed ia TG F -ß 1
0
5 0
1 0 0
1 5 0
2 0 0
2 5 0
C
e
ll
L
y
s
a
te
E
la
s
ti
n
(%
)
* *
M ed ia TG F -ß 1
0
5 0
1 0 0
1 5 0
2 0 0
S
o
lu
b
le
E
la
s
ti
n
(%
)
* * * *
M ed ia TG F -ß 1
0
5 0
1 0 0
1 5 0
M
M
P
-3
(%
)
* * *
M ed ia TG F -ß 1
0
2 0 0
4 0 0
6 0 0
8 0 0
1 0 0 0
P
A
I-
1
(%
)
* * * *
M ed ia TG F -ß 1
0
5 0
1 0 0
1 5 0
D
e
s
m
o
s
in
e
(%
)
* * * *
M ed ia TG F -ß 1
0
5 0
1 0 0
1 5 0
P
ro
lif
e
ra
ti
o
n
(%
) * *
(a) (c)
(d)
(g) (h)
(e) (f)
(i)
(b)
Figure 1. The effect of TGF-β1 on protein levels in normal human dermal fibroblasts (NHDF) cultures. 
Proteins were measured in cell lysates and/or supernatants of NHDF grown in 24 well plates and activated with 
TGF-β1 (5 ng/ml) for 48 hours. Data was expressed as % of media control which was normalised to 100% in 
each experiment. Collagen I and elastin were measured in cell lysates (a,d) and supernatants (b,e), MMP-1 (c), 
MMP-3 (f), PAI-1 (g) and desmosine (h) were measured in supernatants. Proliferation was measured using the 
CyQuant assay (i). The data is presented as mean ± SEM. **indicates P < 0.01, ***P < 0.001, ****P < 0.0001. 
Media control values in (a) = 0.6 ± 0.2 ng/well, n = 11 (b) = 2.5 ± 0.6 ng/well, n = 11 (c) = 22.7 ± 3.5 ng/ml, n = 7 
(d) = 11.4 ± 1.9 µg/well, n = 7 (e) = 6.5 ± 0.8 µg/well, n = 7 (f) = 23.7 ± 6.4 ng/ml, n = 6 (g) = 1618.7 ± 126.3  
pg/ml, n = 8 (h) = 1655 ± 109.2 ng/ml, n = 8 (i) = 25564.5 ± 5758.9 fluorescence units, n = 4.
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We first considered whether the observed increases in collagen and elastin concentrations were due to an 
autocrine effect of TGF-β released by dermal fibroblasts under specific culture conditions. However, TGF-β was 
detected at low (pg/ml) levels (Fig. 4, legend) and found in an inactive form (i.e. requiring acid activation for 
detection). TGF-β was significantly increased in cell lysates (All; 184.2 ± 32%; Fig. 4a) and in supernatants (All; 
119.6 ± 7%; Fig. 4b) in response to collagen peptides in combination with all ACTIVE constituents. However, 
there was no significant increase in TGF-β in either the supernatant (Fig. 4d) or cell lysate (Fig. 4c) in response to 
addition of the constituents of FORTE.
Active TGF-β is a potent inducer of PAI-1 in NHDF culture supernatants (Fig. 1g). However, PAI-1 was not 
increased under any culture condition (data not shown), confirming that TGF-β was present only at low lev-
els and in an inactive form. Further, while TGF-β strongly induced AP-1 activation, detected as an increase in 
phospho-c-jun in cell lysates (Supplementary Fig. S2) the collagen peptides and other bioactives under investiga-
tion did not (data not shown).
Because the measured increases in collagen and elastin potentially reflect reduced degradation by MMP-1 
and MMP-3, respectively, we measured levels of these proteases and their cognate inhibitor, TIMP-1, in cul-
ture supernatants. A highly significant decrease in MMP-1 protein levels in supernatants (Fig. 5a,b) was seen 
in response to collagen peptides alone and the combination of all six ACTIVE constituents (All; 33.8 ± 3% of 
media control; Fig. 5a) and all ten FORTE constituents (All; 47.4 ± 7% of media control; Fig. 5b). The effect of the 
collagen peptides was further significantly increased on addition of the other constituents of FORTE (Fig. 5b). 
In addition, all combinations of ACTIVE and FORTE constituents significantly decreased MMP-1 levels in the 
supernatants (Supplementary Fig. S6a,b), but an additive effect of the FORTE constituents stimulated further 
significant decrease in MMP-1 protein levels compared to collagen peptides alone (Supplementary Fig. S6b).
Similarly, MMP-3 (Fig. 5c,d) was significantly decreased in supernatants in response to collagen peptides 
alone and in the presence of the six ACTIVE ingredients (All; 59.6 ± 18% of media control) and ten FORTE 
ingredients (All; 52 ± 14.8% of media control). The antioxidants and bioactive constituents of FORTE further 
significantly enhanced the effect of the collagen peptides (Fig. 5d). In fact, collagen peptides and all combina-
tions of ACTIVE and FORTE constituents significantly reduced MMP-3 levels in supernatants (Supplementary 
Fig. S6c,d), but an additive effect of the FORTE constituents stimulated further significant decrease in MMP-3 
protein levels compared to collagen peptides alone (Supplementary Fig. S6d).
Figure 2. The effect of collagen peptides alone and in combination with all other bioactives on collagen I levels 
in NHDF cultures. Full length native collagen I was measured in cell lysates (a,c) and supernatants (b,d) of 
NHDF grown in 24 well plates and incubated in media plus collagen peptides alone (C) and in combination 
with the other constituents listed in Table 1 (All) of ACTIVE (a,b) or FORTE (c,d) for 48 hours. Data was 
expressed as % of media control, normalised to 100% in each experiment and is presented as mean ± SEM of 3 
independent experiments. *Indicates P < 0.05. Media control in (a) = 0.7 ± 0.3 ng/well, (b) = 1.3 ± 0.4 ng/well, 
(c) = 0.4 ± 0.1 ng/well and (d) = 2.9 ± 0.9 ng/well.
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In parallel with the significant decrease in MMP-1 and MMP-3 expression, a small but non-significant 
increase in TIMP-1 levels were observed (Fig. 5e,f) with collagen peptides alone that was not altered by addition 
of other constituents of ACTIVE or FORTE supplements.
In parallel with the decrease in MMP-3 concentrations, desmosine as a marker of elastin breakdown 
(Fig. 5g,h) was significantly decreased in response to collagen peptides in combination with all six ACTIVE con-
stituents (All; 72 ± 12.6%; Fig. 5g), and all ten FORTE constituents (All; 64.3 ± 8.2%; Fig. 5h). All combinations 
(Supplementary Fig. S7a,b) of ACTIVE constituents, but only some combinations of FORTE constituents caused 
a significant decrease in the breakdown of elastin.
In view of the lack of evidence for autocrine effects of endogenous TGF-β in the cultures, we considered 
whether the observed inhibition of MMP-1 and MMP-3 expression was related to the total antioxidant activity 
of the added bioactives. In particular, the individual constituents of FORTE appeared to have an additive effect 
(Supplementary Fig. S6), and when added all together they significantly enhanced the effect of the collagen pep-
tides (Fig. 5,b,d and h). The antioxidant activity of the collagen peptides and each of the bioactives under inves-
tigation was measured as peroxyl scavenging activity, and expressed as Trolox equivalents (Table 1). The data 
in Fig. 6 show the strong, significant, negative correlations between the cumulative antioxidant activity of the 
added FORTE constituents and MMP-1 and MMP-3 expression levels (Fig. 6c,d). Further, there is a significant 
negative correlation of soluble elastin with MMP-3 activity (Fig. 6a) and a significant positive correlation with 
antioxidant activity (Fig. 6b), indicating that basal expression and release of MMPs is driven by reactive oxygen 
species and that antioxidant activity added to the cultures was responsible for the further significant inhibition of 
MMP-3 release (Fig. 5d) and increase in soluble elastin (Fig. 3d, Supplementary Fig. S6d) beyond that seen with 
the collagen peptides alone.
Although there was no significant effect on proliferation (Fig. 7) when adding the collagen peptides alone, the 
combination of all ten constituents of FORTE significantly stimulated NHDF proliferation over 48 hours (All; 
123.8 ± 6.5%; Fig. 7b). In addition, incubation of NHDF with HA, a constituent of ACTIVE (Supplementary 
Fig. S8a), and carnosine, a constituent of FORTE (Supplementary Fig. S8b) resulted in significantly increased cell 
proliferation that was not further enhanced by the addition of other bioactives.
Figure 3. The effect of collagen peptides alone and in combination with all other bioactives on elastin levels 
in NHDF cultures. Elastin was measured in cell lysates (a,c) and supernatants (b,d) of NHDF grown in 24 well 
plates and incubated in media plus collagen peptides alone (C) and in combination with the other constituents 
listed in Table 1 (All) of ACTIVE (a,b) or FORTE (c,d) for 48 hours. Data was expressed as % of media control, 
normalised to 100% in each experiment and is presented as mean ± SEM of 4 independent experiments. **/†† 
indicates P < 0.01, ***P < 0.001, ****P < 0.0001. Media control in (a) = 15.2 ± 2.7 µg/well, (b) = 8.3 ± 1.7 µg/well, 
(c) = 10.8 ± 3.4 µg/well and (d) = 6.1 ± 1.7 µg/well. *Indicates groups compared to 0 (media alone), †indicates 
groups compared to 1 (collagen peptides).
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Discussion
TGF-β is a well-recognised pro-fibrotic growth factor that promotes the deposition of ECM proteins, whilst lim-
iting their degradation. The pro-fibrotic effects of TGF-β were confirmed in our model in which normal human 
dermal fibroblasts were cultured under conditions of macromolecular crowding to mimic the extracellular matrix 
environment of the skin. Exogenously added TGF-β1 significantly increased fibroblast proliferation, collagen and 
elastin synthesis and release of PAI-1, while inhibiting release and MMP-1 and MMP-3 and the breakdown of 
elastin. These effects are mediated by SMAD and AP-1 dependent signalling pathways that stimulate synthesis 
of collagen-I via Smad3 and PAI-1 via AP-135 and interact to repress MMP-1 and MMP-3 gene expression36,37. 
Redox signalling also plays an important role in the pro-fibrotic effects of TGF-β38.
Media crowded with macromolecules such as high molecular weight dextran sulphate (0.01% w/v) was 
reported to increase collagen synthesis by embryonic pulmonary fibroblasts 20–30 fold, compared to normal 
media31 and soluble procollagen was completely processed into insoluble collagen by dermal fibroblasts39, 
although the collagen was deposited as aggregates and not fibrils30. Using a sensitive in-house immunoblot 
method to detect collagen I, the presence of soluble collagen I indicated processing was incomplete in our study. 
However, it is possible that the high assay sensitivity detected more soluble collagen I than previous studies.
Collagen peptides significantly increased cell-associated collagen, but only in the presence of glucosamine 
(Supplementary Fig. S3). Positive effects on collagen levels may be associated with the ability of glucosamine to 
stabilise collagen matrices by reducing MMP synthesis, as demonstrated in synovial fibroblasts40. Although we 
found no peroxyl scavenging activity associated with glucosamine (data not shown), superoxide/hydroxyl-radical 
scavenging antioxidant activity of glucosamine hydrochloride has previously been reported, and it was suggested 
that glucosamine hydrochloride could be effectively employed as an ingredient in functional food, to alleviate 
oxidative stress41. However, the lack of any significant effect of adding antioxidants such as resveratrol, CoQ10, 
acai berry, lycopene and pomegranate on collagen expression, despite significant inhibition of MMP-1 expression, 
indicates an effect of glucosamine on collagen synthesis that is not mediated through antioxidant activity.
In contrast, soluble elastin was significantly increased by collagen peptides alone and with all combinations 
of antioxidants and other bioactives tested. Each of the constituent antioxidants found in FORTE appeared to 
have an additive effect on total soluble elastin synthesis. Moreover, when added to fibroblast cultures as the whole 
product (diluted 1:50 to give the same concentrations of the tested individual components), both collagen-based 
nutraceuticals significantly (p < 0.05) increased soluble elastin almost two-fold. This increase in elastin expression 
Figure 4. The effect of collagen peptides alone and in combination with all other bioactives on TGF-β1 
levels in NHDF cultures. TGF-β1 was measured in cell lysates (a,c) and supernatants (b,d) of NHDF grown 
in 24 well plates and incubated in media plus collagen peptides alone (C) and in combination with the other 
constituents listed in Table 1 (All) of ACTIVE (a,b) or FORTE (c,d) for 48 hours. Data was expressed as % 
of media control, normalised to 100% in each experiment and is presented as mean ± SEM of 3 independent 
experiments for ACTIVE and 3 independent experiments for FORTE. *Indicates P < 0.05. Media control in 
(a) = 29.72 ± 12.2 pg/ml, (b) = 49.1 ± 10.3 pg/ml, (c) = 3.6 ± 1.2 pg/ml and (d) = 25 ± 7.5 pg/ml.
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Figure 5. The effect of collagen peptides alone and in combination with all other bioactives on MMP-1, MMP-3 
and TIMP-1 levels and elastin breakdown in NHDF cultures. MMP-1, MMP-3, TIMP-1 and desmosine were 
measured in supernatants of NHDF grown in 24 well plates and incubated in media plus collagen peptides 
alone (C) and in combination with the other constituents listed in Table 1 (All) of ACTIVE (a,c,e,g) or FORTE 
(b,d,f,h) for 48 hours. Data was expressed as % of media control, normalised to 100% in each experiment and 
is presented as mean ± SEM of 3 independent experiments. */†Indicates P < 0.05, **/††P < 0.01, ***P < 0.001, 
****P < 0.0001. Media control in (a) = 26.4 ± 8.2 ng/ml, (b) = 5.6 ± 1.7 ng/ml, (c) = 25.5 ± 8.6 ng/ml, 
(d) = 0.6 ± 0.3 ng/ml, (e) and (f) = 314.1 ± 34.6 ng/ml, (g) = 1.6 ± 0.5 µg/ml and (h) = 1.7 ± 0.5 µg/ml. *Indicates 
groups compared to 0 (media alone), †indicates groups compared to 1 (collagen peptides).
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reflects what has already been observed in vivo. A significant increase in skin firmness (Young’s elasticity) was 
demonstrated in vivo after 90 days of supplementation with both whole collagen-based supplements investigated 
in this study28,29. Low molecular weight avian collagen peptides of similar composition, when orally administered 
in rats, were shown to accumulate preferentially in the skin42, at concentrations which could be scaled to the con-
centration of peptides consumed daily in the test products (100 mg/ml) and used in our in vitro study (2 mg/ml). 
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Figure 6. Correlation between MMP-3 and soluble elastin (a) and the cumulative antioxidant activity of 
individual bioactives in FORTE and soluble elastin (b), MMP-1 (c) and MMP-3 (d) levels in NHDF cultures. A 
one-tailed Pearson correlation coefficient test was used to analyse significance of the data. **Indicates P < 0.01, 
***P < 0.001, ns = no significance.
Figure 7. The effect of collagen peptides alone and in combination with other constituents of ACTIVE and 
FORTE on proliferation of NHDF. Proliferation was measured in NHDF grown in 96 well plates and incubated 
in media plus collagen peptides alone (C) and in combination with the other constituents listed in Table 1 (All) 
of ACTIVE (a) or FORTE (b) for 48 hours. Data was expressed is presented as mean ± SEM of 4 independent 
experiments. Media control value is 19,848 ± 2,476 cells. †Indicates P < 0.05, ***P < 0.001. *Indicates groups 
compared to 0 (media alone), †indicates groups compared to 1 (collagen peptides).
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Thus our in vitro observations support those from our previous in vivo studies, validating the model we have used 
to investigate dermal fibroblast responses to individual components of the products.
The very low levels of TGF-β released (25–50 pg/ml) by dermal fibroblasts in this model, and the lack of effect 
of any of the additives on the levels of active TGF-β, indicated that an autocrine effect of TGF-β was unlikely, and 
this is evidenced by the lack of effect on AP-1 activation and PAI-1 expression.
Collagen peptides alone and in combination with antioxidants and other bioactives significantly reduced 
MMP-1 and MMP-3 expression, in the absence of any change in TIMP-1 levels. Notably, the constituents of 
FORTE appeared to have an additive effect on inhibition of MMPs expression, as was also seen for the increase 
in soluble elastin in culture supernatants. A major cause of ageing-related skin damage is thought to be due to 
increased levels of ROS and oxidative stress14 which directly and indirectly, through increased expression of 
MMPs, damage structural proteins43. MMPs -1, -2, -3 and -9 are mainly responsible for ECM damage and degra-
dation, and can fully degrade collagen together. However, the only MMP that can damage intact collagen I fibres 
is MMP-1, while MMP-3 is capable of degrading elastin43. Protective effects of the collagen peptides and other 
constituents on elastin integrity are indicated by a decrease in desmosine, a cross-linked amino acid and spe-
cific marker of elastin breakdown, in the cultures. The negative correlation of soluble elastin concentration with 
MMP-3 supports the notion that MMP-3 is responsible for elastin breakdown and the generation of desmosine 
in the cultures.
The significant positive association between total peroxyl scavenging activity of the additives and soluble elas-
tin content in the cultures may now suggest a mechanistic role for antioxidant activity in the observed increase in 
soluble elastin. Potentially the effect is mediated by increased elastin transcription in the presence of the antioxi-
dants, as previously shown for the effect of the antioxidant N-acetylcysteine44 or decreased expression of MMP-1 
and MMP-3, which was previously reported for the effect of the antioxidant Tiron45 and mitochondria-targeted 
vitamin E46 on dermal fibroblasts. The significant negative correlation of the MMPs with antioxidant activity 
indicates that the antioxidants are protecting the cells from constitutive intracellular ROS, activation of AP-1 sig-
nalling and MMP expression14. These effects transcend any potential activities associated with the physiological 
(100 µM) concentration of ascorbic acid added to the culture medium as a co-factor for prolyl and lysyl hydroxy-
lases involved in collagen synthesis, since 88–98% of ascorbate disappears from culture medium within 24 h47 and 
we found the peroxyl scavenging activity of 100 µM ascorbic acid was low (6 µM TE).
Finally, collagen peptides in combination with antioxidants and other bioactives under investigation, but not 
alone, stimulated fibroblast proliferation, and the magnitude of the effect was similar to that seen with TGF-β. 
A strong effect of HA on dermal fibroblast proliferation was not further increased by other additions. While HA 
has not been shown to be directly mitogenic48, through facilitating proliferation in response to other mitogenic 
factors such as TGF-β49 and, in this instance, collagen peptides, HA may have an important but indirect role in 
cell proliferation. Similarly, the stimulating effect due to addition of carnosine on fibroblast proliferation was not 
further enhanced by the other additions. McFarland and Holliday (1999) showed in their classical experiments 
that carnosine enhances the proliferative potential of fibroblasts by protecting the cells from telomere shorten-
ing50. Together with stimulating effects on dermal fibroblast proliferation51 carnosine may play an important role 
in skin regeneration.
In conclusion, 48 hour incubation of dermal fibroblasts with collagen-derived peptides and other nutraceu-
tical constituents increases structural ECM protein synthesis, particularly elastin, and decreases synthesis of 
MMPs -1 and -3 and the elastin degradation product desmosine. The effect of these collagen-based supplements 
and their constituents therefore support normal adult human dermal fibroblast function in terms of potentially 
increasing matrix stability in the skin. This effect is not likely to be mediated through TGF-β signalling pathways 
but is more likely correlated with antioxidant effects on dermal fibroblast MMP expression.
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